摘要
目的回顾性总结国内多发性骨髓瘤（MM）患者的临床特征、治疗结果，以提高和改善对MM患者的疗效。方法回顾分析2002年1月1日至12月31日间国内22家医院332例初诊的MM病例。对这些患者进行为期3年的随访。结果一线治疗方案中，325例患者选择化疗，占97．9％，7例患者选择造血干细胞移植（SCT），占2．1％；共有197例（59．4％）患者接受了二线治疗，其中选择化疗和SCT的分别为190例（96．5％）和7例（3．6％）；共有92例（27．7％）患者接受了三线治疗，其中选择化疗和SCT的分别为88例（95．7％）和4例（4．4％）。主要药物不良事件为危及生命的感染19．3％、严重贫血19．3％、深静脉血栓1．2％、血小板减少16．9％、中性粒细胞减少性发热18．1％。结论一些传统MM治疗方案有一定疗效并适合不同患者，期待新的治疗方法进一步改善患者预后。
Objective To describe the demographic and clinical characteristics of patients with the diagnosis of multiple myeloma （MM） and to analyse the outcome of different regimens for the treatment of MM. Methods The study reviewed 332 MM cases diagnosed within the period from January 1, 2002 to December 31, 2002. These patients were tracked via their records to a total period of three years. Results First-line treatment： Totally 332 patients were included, among them 325 （97.9%） patients received chemotherapy and 7（2. 1% ） patients received stem cell transplantation（SCT） ; Second-line treatment： 197 patients were included, among them 190 （96. 5% ） patients received chemotherapy and 7 （3.6%） patients received SCT; Third-line treatment： 92 patients were included, among them 88 （95.7 % ） patients received chemotherapy and 4 （4. 4% ） patients received SCT. Major adverse effects were follows： severe infection 19. 3% ,severe anaemia 19. 3%, phlebothrombosis 1.2%, thrombocytopenia 16. 9%, fever associated with neutropenia 18.1%. Conclusions Some curative effects can be achieved by using traditional treatment plans to treat patients suffering from MM ,but new methods are expected to improve the prognosis.
出处
《中华内科杂志》
CAS
CSCD
北大核心
2008年第2期98-101,共4页
Chinese Journal of Internal Medicine
关键词
多发性骨髓瘤
治疗结果
多中心研究
Multiple myeloma
Treatment outcome
Multicenter studies
